Bioness Stockholders Challenge $110M Sale To Bioventus
An Israeli tech investor has opened a 10-count Delaware Chancery Court class challenge to orthopedic device maker Bioness Inc.'s $110 million acquisition by Bioventus Inc., alleging a low-ball, controller-orchestrated fire sale...To view the full article, register now.
Already a subscriber? Click here to view full article